HOME >> MEDICINE >> NEWS
Alliance congratulates Congress and NIH

Monday, November 29 (Washington, DC) The Alliance for Taxpayer Access, a national coalition of organizations that support enhanced public access to published NIH-funded research, today expressed appreciation to Congress for signaling support through the year-end omnibus appropriations bill for the proposed NIH policy. The conference report for this legislation recognized specifically that the policy will make research results more readily accessible to scientists, physicians, and the public.

Rick Johnson, spokesman for the Alliance and director of the Scholarly Publishing and Academic Resources Coalition (SPARC), added his praise for leaders on Capitol Hill and at the NIH. "Congressional leaders and NIH Director Elias Zerhouni have listened respectfully to all voices in this debate on how to expand access to the published results of NIH-funded science. They agree with us that NIH's primary responsibility is to serve science and to improve human health. We are proud partners with both to ensure that the conduct, scientific review and dissemination of research truly serve the public's interests. We firmly believe the compromise path that NIH has identified, to make research available six months after publication, will address this opportunity intelligently without threatening publishers' livelihoods."

Johnson also noted, "Sunday evening, in its highly-regarded news series called 'Fleecing of America,' the NBC Nightly News underscored the human cost of restricting access to taxpayer-funded research." The story highlighted a cancer patient's campaign for open access to NIH research. (Footage of the NBC clip, "The Fleecing of America" can be viewed at www.msnbc.com by clicking on News Videos located in the left hand column of the website.)


'"/>


29-Nov-2004


Page: 1

Related medicine news :

1. TB Alliance announces new drug discovery program with GlaxoSmithKline
2. Alliance for Taxpayer Access asks NIH Who really owns publicly-funded medical research?
3. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
4. ESMO and Imedex announce partnership for the World Congress on Gastrointestinal Cancer
5. National survey shows few physicians elected to Congress
6. The 23rd Congress of the European Society for Therapeutic Radiology and Oncology (ESTRO)
7. Congress of Neuological Surgeons meets in San Francisco
8. Media invitation - European Society of Cardiology Congress 2004
9. News from the 11th Congress of the International Psychogeriatric Association
10. Many low income Medicare beneficiaries will still face high drug bills under proposals in Congress
11. Report urges Congress to increase medical research

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Alliance congratulates Congress and NIH

(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... are often displayed in the popular Swedish children,s ... of high-sugar foods. A new study from the ... in children,s TV programmes as well as the ... and weight status. , Steingerdur Olafsdottir,s doctoral thesis ... popular Swedish children,s TV show Bolibompa. Healthy foods ...
(Date:4/23/2014)... led by a researcher from the Cancer Science Institute ... Singapore has identified the cancer specific stem cell which ... of developing new drugs for the treatment of this ... group, led by Dr Chan Shing Leng, Research Assistant ... that a cancer-specific variant of a cell surface protein, ...
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... Alzheimer,s disease has been a rapidly evolving pursuit ... latest crook in the research road, scientists have ... proteins associated with the disease. The report, which ... , could have important implications for developing novel ... colleagues explain that for years, research has suggested ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: